Previous Article | Next Article 
Infect Immun, February 1998, p. 645-649, Vol. 66, No. 2
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Occurrence of Virulence-Associated Properties in
Enterobacter cloacae
Rogéria
Keller,1
Margareth Z.
Pedroso,2
Rosana
Ritchmann,3 and
Rosa
M.
Silva1,*
Departamento de Microbiologia, Imunologia, e
Parasitologia1 and
Departamento de
Pediatria,2 Escola Paulista de Medicina,
Universidade Federal de São Paulo, 04023-062 São Paulo,
SP, and
Hospital do Servidor Público Estadual,
04039-030 São Paulo, SP,3 Brazil
Received 14 July 1997/Returned for modification 23 September
1997/Accepted 25 November 1997
 |
ABSTRACT |
Enterobacter cloacae is not a primary human pathogen
but has been considered to be an important cause of nosocomial
infections. Even so, there are almost no reports on its ability to
produce recognized virulence-associated properties. In this study, we show that most of the E. cloacae strains examined were
resistant to serum bactericidal activity and were able to produce
aerobactin and mannose-sensitive hemagglutinin, and all of them could
adhere to and invade HEp-2 cells. Since E. cloacae is part
of the normal intestinal floras of many individuals, we believe that
infectious disease due to endogenous E. cloacae might be a
result of both host predisposing factors and the bacterial virulence
determinants that we have detected in this survey.
 |
INTRODUCTION |
Enterobacter cloacae is
part of the normal flora of the gastrointestinal tract of 40 to 80% of
people and is widely distributed in the environment (15, 19,
39). Like most members of the family
Enterobacteriaceae, these organisms are capable of causing opportunistic infections in hospitalized or debilitated patients (18, 19). They were recognized as a minor cause of hospital infection in a survey published in 1981 (31). Since then,
clinical awareness of the potential of E. cloacae strains to
cause disease has been reflected in the increasing number of
epidemiologic studies of these microorganisms showing that they could
be a serious cause of nosocomial gram-negative bacteremia (9,
17-19, 23).
Many studies have demonstrated that the environment and personnel
usually are not the source for most infections (8, 18, 19).
In fact, it is accepted that these infections often arise from the
patient's endogenous microflora, particularly those of the
gastrointestinal tract (17, 18).
E. cloacae has an intrinsic resistance to ampicillin and
narrow-spectrum cephalosporins and exhibits a high frequency of
mutation to resistance to expanded-spectrum and broad-spectrum
cephalosporins (37, 41). These characteristics, associated
with the frequent endogenous carriage of E. cloacae, may
result in abnormally high levels of this organism in the bowels of
hospitalized patients, especially those who have received
cephalosporins (17, 18). Intestinal overgrowth of a given
species, usually due to antibiotic therapy, may precede bacterial
translocation to mesenteric lymph nodes or to the bloodstream (4,
5). Several authors have suggested that the mechanism of hospital
infections caused by E. cloacae usually corresponds to
endogenous translocation from the digestive tract (4, 5, 17,
18). This idea was proven to be true when in 1992 Lambert-Zechovsky et al. (26) reported for the first time
results of molecular analysis strongly supporting the endogenous nature
of systemic bacteremia and meningitis due to E. cloacae.
Enterobacteria involved in extraintestinal infections, (mainly
Escherichia coli) are known to possess virulence-associated characteristics that distinguish them from random fecal isolates. A
number of studies have elucidated the epidemiology and significance of
these virulence-associated properties, including somatic antigens, adhesins, serum resistance, and production of enterotoxins, colicins, siderophores, and hemolysin (reviewed in reference
16). Moreover, penetration of the epithelial layer
of the intestinal mucosa is a key virulence mechanism of several
enteric pathogens, such as Salmonella, Shigella,
Escherichia, and Yersinia species, which can be
assayed in vitro with human epithelial cell lines, such as HEp-2 cells,
an epidermoid carcinoma line derived from human larynx (2, 14,
27).
The fact that E. cloacae is still considered a typical
commensal and that, so far, there has been no evidence to suggest that its clinical significance extends beyond opportunistic infections may
explain why there are, with rare exceptions, no studies related to its
ability to produce the virulence-associated properties mentioned above
for other microorganisms. To provide an overview of this subject,
we have studied 54 strains of E. cloacae isolated from various sources.
 |
MATERIALS AND METHODS |
Bacterial strains.
A total of 54 E. cloacae
strains were included in this study: 28 from clinical specimens (blood,
urine, and secretions) from hospitalized patients, 5 from catheters, 2 from the scalp, and 19 from the feces of healthy volunteers. All of the
strains had been isolated recently in the diagnostic laboratory of a
Public Health Hospital or at the Discipline of Microbiology, Federal University of São Paulo, São Paulo, Brazil. The strains
were identified as recommended by Brenner (10).
Resistance to serum bactericidal activity.
The resistance of
the bacterial strains to serum bactericidal activity was tested by the
turbidimetric assay performed in 96-well flat-bottom microplates
(Corning, Inc., Corning, N.Y.) according to the methodology described
by Pelkonen and Finne (33). Briefly, an overnight bacterial
growth in Luria-Bertani broth (Difco Laboratories, Detroit, Mich.) was
diluted (1/100) in fresh medium and grown until the exponential phase.
Bacterial cells were harvested and resuspended in 0.1 M
phosphate-buffered-saline (PBS [pH 7.4]) at 4°C to a concentration
of ~107 cells/ml. Seventy-five microliters of each
bacterial suspension was distributed in the microplate wells. An equal
volume of a pool of sera prepared from blood obtained from healthy
human volunteers was added to each well to achieve a final
concentration of 50%. Each strain was tested in triplicate with both
normal serum and heat-inactivated serum (56°C, 30 min). Microplates
were incubated at 37°C, and the growth ability of each strain was
assessed by measurement of the optical density at 620 nm
(OD620) (Titertek-Multiskan MCC/340 MK-2; Flow
Laboratories, Inc., McLean, Va.) for 3 h at 30-min intervals.
E. coli K-12 strain 711 was used as the sensitive control.
The strains were considered serum resistant when they were able to grow
equally in both fresh serum (complement active) and heat-inactivated
serum (complement inactive).
Aerobactin production.
Aerobactin production was assayed by
the method of Carbonetti and Williams (11). Briefly,
E. coli indicator strain LG1522 cells (11) were
grown to 5 × 107 bacteria/ml in 3 ml of M9 broth
supplemented with 0.4% glucose, 50 µg of thiamine per ml, and 200 µM
,
'-dipyridyl (all from Sigma Chemical Company, St. Louis,
Mo.). Bacteria were pour plated (107 cells) on M9 agar
medium. Testing strains grown in the same broth medium were spotted
onto the indicator strain, and plates were incubated for 48 h at
37°C. E. coli LG1315 (43) and K-12 strains were
used as positive and negative controls, respectively.
Hemagglutination activity.
In general, the media and methods
used to test hemagglutination were those described by Adegbola and Old
(1). Bacteria were grown statically in 10 ml of nutrient
broth (Difco) at 30 and 37°C and subcultured six times at 3-day
intervals. The cultures were then centrifuged at 2,000 × g for 15 min and concentrated by resuspension in 1 ml of
saline (NaCl, 0.85% [wt/vol]) to approximately 5 × 109 cells/ml. Fresh chicken, guinea pig, horse, human
(group O only), pig, sheep, and ox erythrocytes and tannic acid
(Sigma)-treated ox erythrocytes were used at a concentration of 3% in
saline. The tests were performed in glass slides by mixing equal
volumes (30 µl) of erythrocytes and bacterial suspensions.
Interaction with HEp-2-cultured cells.
The methods used were
described by Maurelli et al. (30) with modifications. HEp-2
cells (~4 × 105 cells) were grown over tissue
culture coverslips in flat-bottom centrifuge tubes with 19-mm-diameter
(Vidrolabor; Ind. e Com. de Vidros para Laboratórios, São
Paulo, Brazil) containing Eagle's modified minimal essential medium
(DMEM) (Sigma) with 10% (vol/vol) fetal calf serum (FCS) (Cultilab,
Campinas, SP, Brazil) for 48 h at 37°C in an atmosphere of 5%
CO2. After being washed with prewarmed PBS, the monolayer
was infected with ~108 bacteria (determined by OD and
with a growth curve (OD660 × number of viable bacterial
cells) from an overnight growth in tryptic soy broth (Difco),
resuspended in DMEM supplemented with 2% FCS and 2%
D-mannose (Sigma), and centrifuged in a swinging rotor at
600 × g for 10 min at room temperature. After an
incubation period of 2 h at 37°C (infection period), the
monolayer was washed with PBS and then further incubated in fresh
DMEM-2% FCS-2% D-mannose for an additional 4 h
(multiplication period). The monolayer was washed with PBS, and
associated bacteria were released by treatment with 0.1% Triton X-100
(E. Merck, Darmstadt, Germany) in PBS for 5 min at room temperature and
then were quantitated by plate counting. The number of internalized
bacteria was determined as described above, except that 100 µg of
gentamicin (Sigma) per ml was added to kill the extracellular bacteria
during the multiplication period. The results analyzed represent the
mean value of triplicate assays.
To check for adherence pattern and bacterial internalization, the
assays were performed as described above, except that eucaryotic cell
monolayers were grown over tissue culture coverslips. At the end of the
multiplication period, the monolayers were fixed with methanol, stained
with Giemsa (E. Merck), and observed under a light microscope. For
electron microscopy examination, the monolayers were washed in PBS and
fixed with 2.5% glutaraldehyde in 0.05 M sodium cacodylate buffer (pH
7.2) (Sigma). The cells were then gently scraped, washed in 9% sucrose
(Sigma) in the same buffer, and prepared for transmission electron
microscopy as described by Reynolds (34). Nonadherent and
noninvasive laboratory strain E. coli HB101 and
enteroinvasive E. coli strain O28ac 9/82 were used as
controls.
Cytotoxic activity.
Hemolytic activity was determined by the
presence of a clear halo around bacterial colonies after overnight
incubation at 37°C on blood agar base (Difco) with 5% sheep
erythrocytes with or without 10 mM CaCl2 (6).
The cytotoxic effect on HeLa cells was assayed as described by Gentry
(20).
Colony hybridization assays.
The search for DNA homology
with adherence and invasion genes already described for enterobacteria
was performed by colony hybridization according to the method described
by Maas (29). The DNA probes used were labeled by nick
translation (35) with [
-32P]dATP (Amersham
International plc, Buckinghamshire, United Kingdom) and are listed
below: aggregative adherence, 1,000-bp XbaI-SmaI fragment from plasmid pCVD432 (3); diffuse adherence, 350-bp PstI fragment from plasmid pSLM852 (7);
attaching-effacing, 1,000-bp SalI-KpnI fragment
from plasmid pCVD434 (22); and invasion, 2,500-bp
HindIII fragment from plasmid pCVD419 (38).
E. coli K-12 strains carrying the same plasmids used as the
sources of the probe fragments and E. coli K-12 strains
carrying plasmids pBR322 and pUC8 were used as positive and negative
controls, respectively.
 |
RESULTS |
Serum resistance, aerobactin production, and hemagglutination
activity.
As shown in Table 1, serum
resistance (the ability of a bacterial strain to grow in a pool of sera
not depleted of complement as well as in the absence of complement
[achieved by heating]) was a typical feature of most E. cloacae strains in this study. Curiously, the only four sensitive
strains were blood isolates. Aerobactin production was also a very
common characteristic among the strains studied, mainly in those
isolated from blood, secretions, and the scalp (Table 1). A summary of
the hemagglutination abilities of the 54 strains is presented in Table
1. All of the strains could agglutinate guinea pig erythrocytes in the
absence of D-mannose (mannose-sensitive hemagglutination
[MSHA]), except for two strains isolated from feces, which
agglutinated only chicken or tannic acid-treated ox erythrocytes. In
regard to the other erythrocyte species, the most frequently
agglutinated were chicken (87.0%), horse and tannic acid-treated ox
(72.2%), and human (68.5%). It is worth mentioning that about 65% of
the strains were able to agglutinate erythrocytes of at least four
different species. On the contrary, mannose-resistant hemagglutination
(MRHA) was observed with only one strain, which was isolated from urine
(Table 1).
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Detection of serum resistance, aerobactin production, and
hemagglutination activity among E. cloacae isolates from
different sources
|
|
Association with HEp-2 cells.
All of the 54 E. cloacae strains were able to associate with HEp-2 cells in either
a diffuse pattern or in clusters (Fig. 1), regardless of the origin of the
strain. Transmission electron microscopy revealed a very intimate
contact between the bacterium and cell membrane or microvilli (Fig.
2). Quantification of associated bacteria
was performed by counting the CFU per milliliter, and the results are
presented in Table 2. The values were
higher than 106 CFU/ml for 88.9% (48 of 54) of the
strains. Compared to the nonpathogenic E. coli strain HB101,
the great majority of the strains showed a statistically higher
efficiency of association with HEp-2 cells (P < 0.001 [compared by two-tailed Student's t test]).

View larger version (80K):
[in this window]
[in a new window]
|
FIG. 1.
Association of E. cloacae with HEp-2
epithelial cells. Bacterial cells can be seen associated with the
eucaryotic cell membrane in clusters (strain 05/91 [A]) or in a
diffuse adherence pattern (strain 04/91 [B]). Magnification,
×1,000.
|
|

View larger version (185K):
[in this window]
[in a new window]
|
FIG. 2.
Transmission electron micrograph showing adherence of
E. cloacae to HEp-2 cells. Bacterial cells appear in close
contact with the cell membrane and microvilli.
|
|
Since gentamicin does not penetrate the eucaryotic cell membrane, it is
accepted that the survival of HEp-2 cell-associated sensitive bacteria
after gentamicin treatment means that they are internalized. According
to this assumption, although with variable efficiency, all of the 44 gentamicin-sensitive E. cloacae strains tested were able to
internalize into HEp-2 cells (Table 3).
It is important to mention that feces isolates could be as invasive as
blood isolates. It is worth mentioning that the percentage of
associated bacteria that were internalized was usually very low: less
than 2% (0.1 to 1.9%) for 23 strains, between 2 and 8.3% for 16 strains, and between 10.3 and 59.2% for 5 strains. On the other hand,
high association counts were not always accompanied by high invasion
counts. Electron microscopy of HEp-2 cells infected with E. cloacae confirmed its invasion ability (Fig.
3).

View larger version (204K):
[in this window]
[in a new window]
|
FIG. 3.
Transmission electron micrograph showing E. cloacae inside the cytoplasm of HEp-2 cells. The arrow points to a
bacterial cell enclosed by a membrane-bound vacuole.
|
|
Hemolytic activity, cytotoxin production, and hybridization with
DNA probes.
None of the 54 E. cloacae strains tested
were hemolytic, produced cytotoxin in the biological assay, or
hybridized with the adherence and invasion DNA probes used.
 |
DISCUSSION |
It seems likely that the patient's own flora, particularly from
the gastrointestinal tract, may be responsible for the nosocomial infections caused by E. cloacae in debilitated patients.
Since the large intestine is a reservoir of possibly thousands of types of commensal bacteria, it would be reasonable to expect that those which are involved in endogenous extraintestinal infections are apparently more virulent than and possess virulence-associated characteristics that distinguish them from random fecal isolates.
The serum resistance presented by most of the E. cloacae
strains in this study is a common feature of a variety of other
gram-negative bacteria that invade and survive in the human bloodstream
(36, 40). As in the other examples, this finding suggests
that serum resistance may be an important determinant of virulence in
E. cloacae. The only four E. cloacae strains that
we have found to be sensitive to complement-mediated killing were
isolated from blood samples. This is not a controversial result, since
it is already known that serum from some bacteremic patients may be ineffective in bactericidal assays utilizing the infecting, homologous organism, even though the strain is fully susceptible to serum from
healthy individuals (36).
We have shown that E. cloacae is able to produce aerobactin.
The production of this siderophore in one strain of
Enterobacter (Aerobacter) aerogenes
(21) and one strain of E. cloacae (42) has already been reported. There are no other studies, to our knowledge, of the production of aerobactin in clinical isolates of
E. cloacae. Der Vartanian et al. (13) have
suggested that aerobactin influences either the extent of bacterial
translocation from the intestinal tract, the extent of bacterial
multiplication in tissues following translocation, or both. Thus,
aerobactin secretion in vivo could be an important step in the stages
of the infection cycle during which intestine-populating opportunistic bacteria effectively colonize the gut, penetrate the mucous layer covering the intestinal villi, translocate out of intestinal lumen through the epithelial cells, and finally spread to organs within which
they may survive.
The search for the production of hemagglutinins among the E. cloacae strains has demonstrated that all but one produced a mannose-sensitive hemagglutinin compatible with the presence of type 1 fimbriae. On the other hand, MRHA was not found, except for in one
strain isolated from urine. These results are in agreement with those
of Adegbola and Old (1), who found MSHA but not MRHA in most
of the E. cloacae strains studied.
Using the HEp-2 cell-line as a model, it was verified that E. cloacae has the ability to adhere to and invade eucaryotic cells. There was no correlation between adherence and the presence of hemagglutinins, since the adhesion assays were carried out in the
presence of 2% D-mannose, all of the strains were
adherent, and all but one were only MSHA positive. Very recently,
Livrelli et al. (28), studying the adherence of 14 E. cloacae clinical isolates to the human cell line Intestine 407, showed that 10 strains were weakly adherent, while 2 others (one
involved in bloodstream infection) were strongly adherent. In agreement
with our findings, Livrelli et al. have found no relationship between the adhesive pattern and the eventual production of specific fimbriae. Further studies will be carried out in order to determine the adhesin(s) involved in the interaction with HEp-2 cells. Our results have also shown that E. cloacae is in general much less
invasive to HEp-2 cells than the enteroinvasive E. coli
strain used as control. De Kort et al (12) demonstrated that
a strain of E. cloacae isolated from a patient with
septicemia was able to invade and survive within rabbit gut enterocytes
in situ, although with much lower efficiency than that of an invasive
strain of Salmonella typhimurium. We are not aware of any
other reports of the ability of E. cloacae to invade
eucaryotic cells either in vitro or in vivo.
The 54 strains analyzed in this study were unable to produce hemolysin
or cytotoxin. Reports about the production of toxins by E. cloacae are very scarce. Recently, Paton and Paton (32) isolated a strain that produced Shiga-like toxin II-related cytotoxin from a patient with hemolytic-uremic syndrome. Klipstein and Engert (24, 25) have isolated strains capable of producing
heat-stable and heat-labile enterotoxins from patients with tropical
sprue. In our study, the production of enterotoxins was not evaluated, since none of the strains was isolated from patients with
gastrointestinal disease.
Under normal conditions, E. cloacae is no more than a
harmless gut commensal organism. However, in patients receiving
antibiotic therapy, E. cloacae strains may be selected and
may excessively grow in the gastrointestinal tract. This work has shown
that E. cloacae strains, including those isolated from
feces, possess some virulence properties recognized as important in the
onset of extraintestinal infections. Since they have the ability to adhere to and invade eucaryotic cells, it is clear that they would have
the possibility of becoming systemic after intestinal translocation. Once outside the gastrointestinal tract, they would take advantage of
being serum resistant and being able to chelate iron to survive and
spread within the host. There is no doubt about the opportunistic nature of E. cloacae infections, but the presence of
specific virulence determinants may play a definitive role in allowing them to happen.
 |
ACKNOWLEDGMENTS |
We are grateful to Tania A. T. Gomes for kindly providing
the fragment DNA probes and to Mônica A. M. Vieira for
technical assistance with the hybridization procedures. We also thank
E. Freymuller from the Centro de Microscopia Eletrônica,
Escola Paulista de Medicina, Universidade Federal de São Paulo,
for providing the conditions under which we could perform the electron microscopy analysis. We are especially grateful to Tania Mara I. Vaz
from the Section of Bacteriology of Instituto Adolpho Lutz, São
Paulo, Brazil, for confirming the biotyping of the strains. Finally,
our special thanks goes to Lilian R. M. Marques for critical review of the manuscript.
This work was supported by Centro de Aperfeiçoamento de Pessoal
de Nível Superior, CAPES.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Disciplina de
Microbiologia, Dept. Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, UNIFESP, Rua Botucatu, 862-3o
Andar-V.Clementino, CEP 04023-062 São Paulo, SP, Brazil. Phone: (011) 5084-3213. Fax: (011) 5716504. E-mail:
rmsilva.dmip{at}epm.br.
Editor: P. E. Orndorff
 |
REFERENCES |
| 1.
|
Adegbola, R. A., and D. C. Old.
1983.
Fimbrial haemagglutinins in Enterobacter species.
J. Gen. Microbiol.
129:2175-2180[Medline].
|
| 2.
|
Baldini, M. M.,
J. P. Nataro, and J. B. Kaper.
1986.
Localization of a determinant for HEp-2 adherence by enteropathogenic Escherichia coli.
Infect. Immun.
52:334-336[Abstract/Free Full Text].
|
| 3.
|
Baudry, B.,
S. J. Savarino,
P. Vial,
J. B. Kaper, and M. M. Levine.
1990.
A sensitive and specific DNA probe to identify enteroaggregative Escherichia coli, a recently discovered diarrheal pathogen.
J. Infect. Dis.
161:1249-1251[Medline].
|
| 4.
|
Berg, R. D.
1983.
Translocation of indigenous bacteria from the intestinal tract, p. 333-351. In
D. J. Hentges (ed.), Human intestinal microflora in health and disease.
Academic Press, Inc., New York, N.Y.
|
| 5.
|
Berg, R. D., and A. W. Garlington.
1979.
Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model.
Infect. Immun.
23:403-411[Abstract/Free Full Text].
|
| 6.
|
Beutin, L.
1991.
The different hemolysins of Escherichia coli.
Med. Microbiol. Immunol.
180:167-182[Medline].
|
| 7.
|
Bilge, S. S.,
C. R. Clausen,
W. Lau, and S. L. Moseley.
1989.
Molecular characterization of a fimbrial adhesin, F1845, mediating diffuse adherence of diarrhea-associated Escherichia coli to HEp-2 cells.
J. Bacteriol.
171:4281-4289[Abstract/Free Full Text].
|
| 8.
|
Bingen, E.,
E. Denamur,
N. Lambert-Zechovsky,
N. Brahhimi,
M. El Lakany, and J. Elion.
1992.
Rapid genotyping shows the absence of cross-contamination in Enterobacter cloacae nosocomial infection.
J. Hosp. Infect.
21:95-101[Medline].
|
| 9.
|
Bodey, G. P.,
L. S. Elting, and S. Rodriguez.
1991.
Bacteremia caused by Enterobacter: 15 years of experience in a cancer hospital.
Rev. Infect. Dis.
13:550-558[Medline].
|
| 10.
|
Brenner, D. J.
1981.
The genus Enterobacter, p. 1173-1180. In
M. P. Starr, H. Stopl, H. G. Trüper, A. Ballows, and H. G. Schlegel (ed.), The prokaryotes. A handbook of habitats, isolation, and identification of bacteria, vol. II.
Springer-Verlag, Berlin, Germany.
|
| 11.
|
Carbonetti, N. H., and P. H. Williams.
1984.
A cluster of five genes specifying the aerobactin iron uptake system of plasmid ColV-K30.
Infect. Immun.
46:7-12[Abstract/Free Full Text].
|
| 12.
|
De Kort, G.,
A. Bolton,
G. Martin,
J. Stephen, and J. A. M. van de Klundert.
1994.
Invasion of rabbit ileal tissue by Enterobacter cloacae varies with the concentration of OmpX in the outer membrane.
Infect. Immun.
62:4722-4726[Abstract/Free Full Text].
|
| 13.
|
Der Vartanian, M.,
B. Jaffeux,
M. Contrepois,
M. Chavarot,
J.-P. Girardeau,
Y. Bertin, and C. Martin.
1992.
Role of aerobactin in systemic spread of an opportunistic strain of Escherichia coli from the intestinal tract of gnotobiotic lambs.
Infect. Immun.
60:2800-2807[Abstract/Free Full Text].
|
| 14.
|
Donnenberg, M. S.,
A. Donohue-Rolfe, and G. T. Keusch.
1990.
A comparison of HEp-2 cell invasion by enteropathogenic and enteroinvasive Escherichia coli.
FEMS Microbiol. Lett.
57:83-86[Medline].
|
| 15.
|
Dudley, D. J.,
M. N. Guentzel,
M. J. Ibarra,
B. E. Moore, and B. P. Sagik.
1980.
Enumeration of potentially pathogenic bacteria from sewage sludges.
Appl. Environ. Microbiol.
39:118-126[Abstract/Free Full Text].
|
| 16.
|
Eisenstein, B. I., and G. W. Jones.
1988.
The spectrum of infections and pathogenic mechanisms of Escherichia coli.
Adv. Intern. Med.
33:231-252[Medline].
|
| 17.
|
Falkiner, F. R.
1992.
Enterobacter in hospital.
J. Hosp. Infect.
20:137-140[Medline].
|
| 18.
|
Flynn, D. M.,
R. A. Weinstein,
C. Nathan,
M. A. Gaston, and S. A. Kabins.
1987.
Patients' endogenous flora as a source of "nosocomial" Enterobacter in cardiac surgery.
J. Infect. Dis.
156:363-368[Medline].
|
| 19.
|
Gaston, M. A.
1988.
Enterobacter: an emerging nosocomial pathogen.
J. Hosp. Infect.
11:197-208[Medline].
|
| 20.
|
Gentry, M. K., and J. M. Dalrymple.
1980.
Quantitative microtiter cytotoxicity assay for Shigella toxin.
J. Clin. Microbiol.
12:361-366[Abstract/Free Full Text].
|
| 21.
|
Gibson, F., and D. I. Margrath.
1969.
The isolation and characterization of hydroxamic acid (aerobactin) formed by Aerobacter aerogenes.
Biochim. Biophys. Acta
192:175-184[Medline].
|
| 22.
|
Jerse, A. E.,
J. Yu,
B. D. Tall, and J. B. Kaper.
1990.
A genetic locus of enteropathogenic E. coli necessary for the production of attaching and effacing lesions on tissue culture cells.
Proc. Natl. Acad. Sci. USA
87:7839-7843[Abstract/Free Full Text].
|
| 23.
|
John, J. F., Jr.,
R. J. Sharbaugh, and E. R. Bannister.
1982.
Enterobacter cloacae: bacteremia, epidemiology, and antibiotic resistance.
Rev. Infect. Dis.
4:13-28[Medline].
|
| 24.
|
Klipstein, F. A., and R. F. Engert.
1976.
Partial purification and properties of Enterobacter cloacae heat-stable enterotoxin.
Infect. Immun.
13:1307-1314[Abstract/Free Full Text].
|
| 25.
|
Klipstein, F. A., and R. F. Engert.
1977.
Immunological interrelationships between cholera toxin and the heat-labile and heat-stable enterotoxins of coliform bacteria.
Infect. Immun.
18:110-117[Abstract/Free Full Text].
|
| 26.
|
Lambert-Zechovsky, N.,
E. Bingen,
E. Denamur,
N. Brahimi,
P. Brun,
H. Mathieu, and J. Elion.
1992.
Molecular analysis provides evidence for the endogenous origin of bacteremia and meningitis due to Enterobacter cloacae in an infant.
Clin. Infect. Dis.
15:30-32[Medline].
|
| 27.
|
Lassen, J., and G. Kapperud.
1986.
Serotype-related HEp-2 cell interaction of Yersinia enterocolitica.
Infect. Immun.
52:85-89[Abstract/Free Full Text].
|
| 28.
|
Livrelli, V.,
C. De Champs,
P. Di Martino,
A. Darfeuille-Michaud,
C. Forestier, and B. Joly.
1996.
Adhesive properties and antibiotic resistance of Klebsiella, Enterobacter, and Serratia clinical isolates involved in nosocomial infections.
J. Clin. Microbiol.
34:1963-1969[Abstract].
|
| 29.
|
Maas, R.
1983.
An improved colony hybridization method with significantly increased sensitivity for detection of single genes.
Plasmid
10:296-298[Medline].
|
| 30.
|
Maurelli, A. T.,
B. Blackmon, and R. Curtiss, III.
1984.
Temperature-dependent expression of virulence genes in Shigella species.
Infect. Immun.
43:195-201[Abstract/Free Full Text].
|
| 31.
| National Survey of Infection in Hospitals. 1981. The general distribution of infection. J. Hosp. Infect.
2(Suppl.):13-17.
|
| 32.
|
Paton, A. W., and J. C. Paton.
1996.
Enterobacter cloacae producing a Shiga-like toxin II-related cytotoxin associated with a case of hemolytic-uremic syndrome.
J. Clin. Microbiol.
34:463-465[Abstract].
|
| 33.
|
Pelkonen, S., and J. Finne.
1987.
A rapid turbidimetric assay for the study of serum sensitivity of Escherichia coli.
FEMS Microbiol. Lett.
42:53-57.
|
| 34.
|
Reynolds, E. S.
1963.
The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.
J. Cell. Biol.
17:208-212[Free Full Text].
|
| 35.
|
Rigby, P. W. J.,
M. Diekman,
C. Rhodes, and P. Berg.
1977.
Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.
J. Mol. Biol.
113:237-251[Medline].
|
| 36.
|
Roantree, R. J., and L. A. Rantz.
1960.
A study of the relationship of the normal bactericidal activity of human serum to bacterial infection.
J. Clin. Invest.
39:72-81.
|
| 37.
|
Sanders, C. C., and W. E. Sanders, Jr.
1983.
Emergence of resistance during therapy with the newer -lactam antibiotics: role of inducible -lactamase and implications for the future.
Rev. Infect. Dis.
5:639-648[Medline].
|
| 38.
|
Small, P. L. C., and S. Falkow.
1986.
Development of a DNA probe for the virulence plasmid of Shigella spp. and enteroinvasive Escherichia coli, p. 121-124. In
L. Leive, P. F. Bonventre, T. A. Morello, S. D. Silver, and H. C. Wu (ed.), Microbiology 1986.
American Society for Microbiology, Washington, D.C.
|
| 39.
|
Sommers, H. M.
1985.
The indigenous microbiota of the human host, p. 65-80. In
G. P. Youmans, P. Y. Paterson, and H. M. Sommers (ed.), The biologic and clinical basis of infectious diseases.
Saunders, Philadelphia, Pa.
|
| 40.
|
Taylor, P. W.
1983.
Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.
Microbiol. Rev.
47:46-83[Free Full Text].
|
| 41.
|
Then, R. L.
1987.
Ability of newer beta-lactam antibiotics to induce beta-lactamase production in Enterobacter cloacae.
Eur. J. Clin. Microbiol.
6:451-455[Medline].
|
| 42.
|
Van Tiel-Menkveld, G. J.,
J. M. Vervuurt,
B. Oudega, and F. K. de Graaf.
1982.
Siderophore production by Enterobacter cloacae and a common receptor protein for the uptake of aerobactin and cloacin DF13.
J. Bacteriol.
150:490-497[Abstract/Free Full Text].
|
| 43.
|
Williams, P. H., and P. J. Warner.
1980.
ColV plasmid-mediated colicin V-independent iron uptake system of invasive strains of Escherichia coli.
Infect. Immun.
29:411-416[Abstract/Free Full Text].
|
Infect Immun, February 1998, p. 645-649, Vol. 66, No. 2
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Hoffmann, H., Roggenkamp, A.
(2003). Population Genetics of the Nomenspecies Enterobacter cloacae. Appl. Environ. Microbiol.
69: 5306-5318
[Abstract]
[Full Text]
-
Vieira, A. B.R., Koh, I. H.J., Guth, B. E.C.
(2003). Providencia alcalifaciens strains translocate from the gastrointestinal tract and are resistant to lytic activity of serum complement. J Med Microbiol
52: 633-636
[Abstract]
[Full Text]